> Athenagen, a Menlo Park, Ca.-based start-up, has garnered $5.69 million in its first round of venture financing. The financing was led by Sanderling Ventures and included participation from Life Science Angels. Release
> Barrier Therapeutics of Princeton, N.J. has released positive Phase IIa results for the acne therapy Rambazole. Release
> Canada's Cangene has won a $17 million contract from the UK for Vaccinia immune globulin. Report
> Oscient Pharmaceuticals has released full results from its late-stage trial comparing five- and seven-day treatments of Factive tablets for pneumonia. Story
> Toronto-based Viventia Biotech has received FDA clearance to start a mid-stage trial of its cancer drug Proxinium. Release
And finally…Singapore will boost investments in its biotechnology sector to $7 billion over the next five years. Article